Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Apple
AAPL
|
$1.03B |
| 2 |
Broadcom
AVGO
|
$1.01B |
| 3 |
SPDR Portfolio S&P 500 ETF
SPLG
|
$892M |
| 4 |
Amazon
AMZN
|
$876M |
| 5 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
$765M |
Top Sells
| 1 |
Advanced Micro Devices
AMD
|
$459M |
| 2 |
Yum China
YUMC
|
$421M |
| 3 |
Merck
MRK
|
$362M |
| 4 |
ASML
ASML
|
$313M |
| 5 |
Microchip Technology
MCHP
|
$298M |
Sector Composition
| 1 | Technology | 24.74% |
| 2 | Financials | 12.44% |
| 3 | Industrials | 11.72% |
| 4 | Healthcare | 10.66% |
| 5 | Consumer Discretionary | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3551
iShares Russell 2000 ETF
IWM
$67.8B
| $59.9K | ﹤0.01% |
271
-53
| -16% | -$11.7K |
|
3552
Nautilus Biotechnolgy
NAUT
$83.5M
| $58.8K | ﹤0.01% |
20,620
-625
| -3% | -$1.78K |
|
3553
ProKidney
PROK
$304M
| $58.5K | ﹤0.01% |
30,480
+2,617
| +9% | +$5.03K |
|
3554
OppFi
OPFI
$297M
| $58.5K | ﹤0.01% |
12,360
-43,501
| -78% | -$206K |
|
3555
Porch Group
PRCH
$1.9B
| $57.8K | ﹤0.01% |
37,672
+424
| +1% | +$651 |
|
3556
Forge Global Holdings
FRGE
$235M
| $56.6K | ﹤0.01% |
2,882
-145
| -5% | -$2.85K |
|
3557
Lineage Cell Therapeutics
LCTX
$279M
| $54.8K | ﹤0.01% |
60,513
+3,749
| +7% | +$3.39K |
|
3558
Cadiz
CDZI
$291M
| $54.7K | ﹤0.01% |
18,066
+231
| +1% | +$700 |
|
3559
Prime Medicine
PRME
$663M
| $54.3K | ﹤0.01% |
14,023
+586
| +4% | +$2.27K |
|
3560
Stereotaxis
STXS
$264M
| $54.1K | ﹤0.01% |
26,524
+197
| +0.7% | +$402 |
|
3561
ASP Isotopes
ASPI
$755M
| $53.8K | ﹤0.01% |
19,343
+217
| +1% | +$603 |
|
|
AMRN
3562
Amarin Corp
AMRN
$317M
| $53.6K | ﹤0.01% |
4,277
+1,311
| +44% | +$16.4K |
|
3563
Kaltura
KLTR
$226M
| $53.5K | ﹤0.01% |
39,319
+2,802
| +8% | +$3.81K |
|
3564
Paysign
PAYS
$286M
| $53.4K | ﹤0.01% |
14,541
-32,844
| -69% | -$121K |
|
3565
MeiraGTx Holdings
MGTX
$619M
| $53K | ﹤0.01% |
12,701
+535
| +4% | +$2.23K |
|
3566
PDS Biotechnology
PDSB
$56.4M
| $52.8K | ﹤0.01% |
13,815
+641
| +5% | +$2.45K |
|
3567
Seres Therapeutics
MCRB
$169M
| $52.2K | ﹤0.01% |
2,761
+798
| +41% | +$15.1K |
|
3568
Lantronix
LTRX
$185M
| $50.7K | ﹤0.01% |
+12,314
| New | +$50.7K |
|
3569
Information Services Group
III
$253M
| $50.4K | ﹤0.01% |
15,275
-85,491
| -85% | -$282K |
|
3570
1stdibs.com
DIBS
$100M
| $50K | ﹤0.01% |
11,335
-347
| -3% | -$1.53K |
|
3571
Denison Mines
DNN
$2.11B
| $48.6K | ﹤0.01% |
26,567
-1,405
| -5% | -$2.57K |
|
3572
FibroGen
FGEN
$48.9M
| $48.3K | ﹤0.01% |
4,837
+3,460
| +251% | +$34.5K |
|
3573
Karyopharm Therapeutics
KPTI
$57.2M
| $48.3K | ﹤0.01% |
3,877
+1,176
| +44% | +$14.6K |
|
3574
Veru
VERU
$49.4M
| $48.1K | ﹤0.01% |
6,261
-11
| -0.2% | -$85 |
|
3575
Rigetti Computing
RGTI
$4.89B
| $48K | ﹤0.01% |
61,339
-2,688
| -4% | -$2.11K |
|